These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Granulocytopenia in treatment with salazopyrin]. Kvarstein G; Hovdenak N Tidsskr Nor Laegeforen; 1988 Nov; 108(32):2982-3. PubMed ID: 2908084 [No Abstract] [Full Text] [Related]
7. Sulfasalazine associated agranulocytosis in Sweden 1972-1989. Clinical features, and estimation of its incidence. Keisu M; Ekman E Eur J Clin Pharmacol; 1992; 43(3):215-8. PubMed ID: 1358622 [TBL] [Abstract][Full Text] [Related]
9. Immunologic mechanism in sulphasalazine-induced agranulocytosis. Victorino RM; Maria VA; de Deus J Acta Haematol; 1990; 84(2):111. PubMed ID: 1977273 [No Abstract] [Full Text] [Related]
10. Sulphasalazine induced agranulocytosis in a patient with rheumatoid arthritis. Murphy PT; O'Donnell JR Ir J Med Sci; 1990 Jun; 159(6):195. PubMed ID: 1977725 [No Abstract] [Full Text] [Related]
11. [Agranulocytosis in rheumatoid polyarthritis treated with sulfasalazine]. Pointud P; Cauhape P; Favreau A Rev Rhum Mal Osteoartic; 1989 Jun; 56(7):573. PubMed ID: 2569228 [No Abstract] [Full Text] [Related]
19. Fatal agranulocytosis with sulfasalazine therapy in rheumatoid arthritis. Canvin JM; el-Gabalawy HS; Chalmers IM J Rheumatol; 1993 May; 20(5):909-10. PubMed ID: 8101571 [No Abstract] [Full Text] [Related]
20. Comparing risk estimates of sulphonamide-induced agranulocytosis from the Swedish Drug Monitoring System and a case-control study. Keisu M; Ekman E; Wiholm BE Eur J Clin Pharmacol; 1992; 43(3):211-4. PubMed ID: 1358621 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]